ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

BLUE bluebird bio Inc

0,9399
0,0274 (3,00%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
bluebird bio Inc BLUE NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,0274 3,00% 0,9399 06:00:10
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,9102 0,893 0,9458 0,9228 0,9125
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
26.4.202422:05BWbluebird bio Announces Receipt of Expected Notice from..
26.4.202411:45PRNUSBLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird..
19.4.202411:45PRNUSbluebird bio, Inc. Sued for Securities Law Violations -..
16.4.202411:45PRNUSClass Action Filed Against bluebird bio, Inc. (BLUE) Seeking..
12.4.202411:45PRNUSShareholders that lost money on bluebird bio, Inc.(BLUE)..
11.4.202414:00BWbluebird bio Reports Inducement Grants Under Nasdaq Listing..
09.4.202411:45PRNUSbluebird bio, Inc. Sued for Securities Law Violations -..
05.4.202411:45PRNUSShareholders that lost money on bluebird bio, Inc.(BLUE)..
26.3.202412:01BWbluebird bio Reports Fourth Quarter and 2023 Annual Results..
25.3.202421:05BWbluebird bio to Host Fourth Quarter and 2023 Annual Results..
18.3.202413:00BWbluebird bio Secures up to $175 Million Debt Financing with..
11.3.202413:00BWbluebird bio Announces First Outcomes-Based Agreement with..
05.3.202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202419:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06.2.202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202422:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.1.202414:03EDGAR2Form 8-K - Current report
08.1.202414:00BWbluebird bio Provides Update on Commercial Launch Progress,..
04.1.202414:00EDGAR2Form 8-K - Current report
02.1.202414:00BWbluebird bio to Present at the 42nd Annual J.P. Morgan..
20.12.202323:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20.12.202313:42EDGAR2Form 8-K - Current report
20.12.202303:41BWbluebird bio, Inc. Announces Pricing of $125 Million Public..
19.12.202312:10IHMARKETNEWSGoogle $700M Antitrust Settlement, TSMC Chairman Retirement,..
18.12.202323:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18.12.202322:48EDGAR2Form 8-K - Current report
18.12.202322:01BWbluebird bio, Inc. Announces Proposed Public Offering of..
14.12.202313:30EDGAR2Form 8-K - Current report
11.12.202314:06EDGAR2Form 8-K - Current report
10.12.202318:02BWLong-Term Data Presented at ASH Support beti-cel as a..
09.12.202317:31BWLong-term Follow-up Data From bluebird’s Gene Therapy..
08.12.202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.12.202322:11DJNBluebird Bio Shares Slide 41% on Black-Box Label, Higher..
08.12.202319:01BWbluebird bio Details Plans for the Commercial Launch of..
08.12.202318:35BWbluebird bio Announces FDA Approval of LYFGENIA™..
08.12.202318:03DJNBluebird Bio Gets FDA OK of Lyfgenia Gene Therapy in..
07.11.202313:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202313:01EDGAR2Form 8-K - Current report
07.11.202313:00BWbluebird bio Reports Third Quarter 2023 Financial Results..
03.11.202321:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202321:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202314:37BWbluebird bio to Present New and Updated Data from Gene..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock